The emergence of brain-inspired neuromorphic computing as a paradigm for edge AI is motivating the search for high-performance and efficient spiking neural networks to run on this hardware. However, compared to classical neural networks in deep learning, current spiking neural networks lack competitive performance in compelling areas. Here, for sequential and streaming tasks, we demonstrate how a novel type of adaptive spiking recurrent neural network (SRNN) is able to achieve state-of-the-art performance compared to other spiking neural networks and almost reach or exceed the performance of classical recurrent neural networks (RNNs) while exhibiting sparse activity. From this, we calculate a >100x energy improvement for our SRNNs over classical RNNs on the harder tasks. To achieve this, we model standard and adaptive multiple-timescale spiking neurons as self-recurrent neural units, and leverage surrogate gradients and auto-differentiation in the PyTorch Deep Learning framework to efficiently implement backpropagation-through-time, including learning of the important spiking neuron parameters to adapt our spiking neurons to the tasks. CCS CONCEPTS• Computing methodologies → Neural networks; Supervised learning by classification; Continuous models.
Motivation Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease caused by aberrations in the genome. While several disease-causing variants have been identified, a major part of heritability remains unexplained. ALS is believed to have a complex genetic basis where non-additive combinations of variants constitute disease, which cannot be picked up using the linear models employed in classical genotype–phenotype association studies. Deep learning on the other hand is highly promising for identifying such complex relations. We therefore developed a deep-learning based approach for the classification of ALS patients versus healthy individuals from the Dutch cohort of the Project MinE dataset. Based on recent insight that regulatory regions harbor the majority of disease-associated variants, we employ a two-step approach: first promoter regions that are likely associated to ALS are identified, and second individuals are classified based on their genotype in the selected genomic regions. Both steps employ a deep convolutional neural network. The network architecture accounts for the structure of genome data by applying convolution only to parts of the data where this makes sense from a genomics perspective. Results Our approach identifies potentially ALS-associated promoter regions, and generally outperforms other classification methods. Test results support the hypothesis that non-additive combinations of variants contribute to ALS. Architectures and protocols developed are tailored toward processing population-scale, whole-genome data. We consider this a relevant first step toward deep learning assisted genotype–phenotype association in whole genome-sized data. Availability and implementation Our code will be available on Github, together with a synthetic dataset (https://github.com/byin-cwi/ALS-Deeplearning). The data used in this study is available to bona-fide researchers upon request. Supplementary information Supplementary data are available at Bioinformatics online.
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease caused by aberrations in the genome. While several disease-causing variants have been identified, a major part of heritability remains unexplained. ALS is believed to have a complex genetic basis where nonadditive combinations of variants constitute disease, which cannot be picked up using the linear models employed in classical genotype-phenotype association studies. Deep learning on the other hand is highly promising for identifying such complex relations. We therefore developed a deep-learning based approach for the classification of ALS patients versus healthy individuals from the Dutch cohort of the ProjectMinE dataset. Based on recent insight that regulatory regions on the genome play a major role in ALS, we employ a two-step approach: first promoter regions that are likely associated to ALS are identified, and second individuals are classified based on their genotype in the selected genomic regions. Both steps employ a deep convolutional neural network. The network architecture accounts for the structure of genome data by applying convolution only to parts of the data where this makes sense from a genomics perspective.Our approach identifies potential ALS-associated genetic variants, and generally outperforms other classification methods. Test results support the hypothesis that ALS is caused by non-additive combinations of variants. Our method can be applied to large-scale whole genome data. We consider this a first step towards genotype-phenotype association with deep learning that is tailored to genomics and can deal with genome-sized data.
The folding structure of the DNA molecule combined with helper molecules, also referred to as the chromatin, is highly relevant for the functional properties of DNA. The chromatin structure is largely determined by the underlying primary DNA sequence, though the interaction is not yet fully understood. In this paper we develop a convolutional neural network that takes an image-representation of primary DNA sequence as its input, and predicts key determinants of chromatin structure. The method is developed such that it is capable of detecting interactions between distal elements in the DNA sequence, which are known to be highly relevant. Our experiments show that the method outperforms several existing methods both in terms of prediction accuracy and training time.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.